logo-banner-small.png
Relay Therapeutics Announces Pricing of Public Offering of Common Stock
September 10, 2024 20:21 ET | Relay Therapeutics, Inc.
Relay Therapeutics Announces Pricing of Public Offering of Common Stock
logo-banner-small.png
Relay Therapeutics Announces Proposed Public Offering of Common Stock
September 09, 2024 16:34 ET | Relay Therapeutics, Inc.
Relay Therapeutics Announces Proposed Public Offering of Common Stock
logo-banner-small.png
Relay Therapeutics Announces Positive Interim Data for RLY-2608 Demonstrating Clinically Meaningful Progression Free Survival
September 09, 2024 06:55 ET | Relay Therapeutics, Inc.
Relay Therapeutics Announces Positive Interim Data for RLY-2608 Demonstrating Clinically Meaningful Progression Free Survival
logo-banner-small.png
Relay Therapeutics Announces Webcast to Report RLY-2608 Data on September 9, 2024
September 06, 2024 16:05 ET | Relay Therapeutics, Inc.
Relay Therapeutics Announces Webcast to Report RLY-2608 Data on September 9, 2024
logo-banner-small.png
Relay Therapeutics Reports Second Quarter 2024 Financial Results and Corporate Highlights
August 06, 2024 16:05 ET | Relay Therapeutics, Inc.
Relay Therapeutics Reports Second Quarter 2024 Financial Results and Corporate Highlights
logo-banner-small.png
Relay Therapeutics to Announce Second Quarter 2024 Financial Results and Corporate Highlights on August 6, 2024
July 30, 2024 16:05 ET | Relay Therapeutics, Inc.
Relay Therapeutics to Announce Second Quarter 2024 Financial Results and Corporate Highlights on August 6, 2024
logo-banner-small.png
Relay Therapeutics Discloses Three New Programs at New Program & Platform Event
June 06, 2024 07:00 ET | Relay Therapeutics, Inc.
Relay Therapeutics Discloses Three New Programs at New Program & Platform Event
logo-banner-small.png
Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608
June 05, 2024 16:05 ET | Relay Therapeutics, Inc.
CAMBRIDGE, Mass., June 05, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining...
logo-banner-small.png
Relay Therapeutics to Participate in Upcoming Investor Conferences
May 21, 2024 16:05 ET | Relay Therapeutics, Inc.
Relay Therapeutics to Participate in Upcoming Investor Conferences
logo-banner-small.png
Relay Therapeutics to Host New Program and Platform Event on June 6, 2024
May 13, 2024 08:30 ET | Relay Therapeutics, Inc.
Relay Therapeutics to Host New Program and Platform Event on June 6, 2024